Cytiva is a privately owned company headquartered in the US. Founded in 1968, the company provides life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman.
On September 28, 2026, Cytiva shared practical strategies via a webinar to address protein purification bottlenecks in early-stage development, advocating for parallel chromatography, automation, and smart software features to process more samples. Earlier on the same day, Cytiva's Sr. Product Marketing Manager Automation and Digital Martin Ball and Senior Product Director Automation and Digital Ashley Howard discussed challenges in modern biopharma manufacturing, including process execution, observability, digital transformation, and reliability, focusing on building trust in model-driven manufacturing. Previously, on September 24, 2026, the company highlighted the benefits of modern polyethersulfone (PES) membranes for the sterile filtration of cell culture media, noting their significant increase in capacity and flow, as well as relatively low extractables, compared to traditional hydrophilic polyvinylidene difluoride (PVDF) membranes.
Subscribe for full access to Cytiva's products in full detail
Subscribe for full access to Cytiva's revenue in full detail
Subscribe for full access to Cytiva's products in full detail 
